Catalyst Wire Dossier Catalyst Wire Dossier

IDA

Ivermectin + Diethylcarbamazine + Albendazole
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for IDA, covering 2019-02-28 to 2023-05-10. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy of IDA for Onchocerciasis [Phase 2]

See pricing